Navigation Links
Whitehead member Rudolf Jaenisch honored for groundbreaking stem cell research

CAMBRIDGE, Mass. (February 16, 2011) Israel's Wolf Foundation, whose stated mission is "to promote science and art for the benefit of mankind," has named Whitehead Institute Founding Member Rudolf Jaenisch a recipient of the prestigious 2011 Wolf Prize in Medicine.

Jaenisch will share this year's prize with Kyoto University's Shinya Yamanaka for what the Wolf Foundation describes as "their groundbreaking contribution to stem cell research."

Yamanaka is being recognized for his 2006 experiments showing that four genes inserted into mouse skin cells can confer on the cells the properties of embryonic stem cellsincluding pluripotency, or the ability to differentiate into virtually any mammalian cell type. Yamanaka's work, the generation of so-called induced pluripotent stem cells, or iPS cells, ushered in a new area of cellular reprogramming.

The following year, Jaenisch advanced Yamanaka's work with the first experiments to demonstrate the therapeutic potential of iPS cells. Jaenisch reprogrammed mouse skin cells into iPS cells, corrected a genetic defect in the cells, and then used the cells to cure a mouse model of sickle-cell anemia. He later used a similar approach to treat a model of Parkinson's disease in rats.

In announcing this year's award, the Wolf Prize Committee stated: "Collectively, the groundbreaking contributions by Dr. Yamanka and Dr. Jaenisch form the basis for work on regenerative medicine currently performed in hundreds of laboratories around the world."

"I'm really very, very honored by this," says Jaenisch. "To be recognized with Shinya Yamanaka in this way is just incredibly gratifying."

The Wolf Prize in Medicine is the third significant honor Jaenisch and Yamanaka have shared in recent years. In late 2008, both were named recipients of the Meira and Shaul G. Massry Prize, and this spring, both will receive the Warren Triennial Prize from Massachusetts General Hospital. For Whitehead Institute Director David Page, such recognition for his long-time colleague hardly comes as a surprise.

"This latest honor for Rudolf is further validation of his pioneering work in cellular reprogramming," Page says. "Rudolf has consistently led the way in applying novel techniques in this arena to the treatment of human disease. He's more than deserving of these accolades."

The Israel-based Wolf Foundation, established by the late German-born inventor, diplomat and philanthropist, Dr. Ricardo Wolf, has awarded five Wolf Prizes annually since 1978 to outstanding scientists and artists "for achievements in the interest of mankind and friendly relations among peoples, irrespective of nationality, race, color, religion, sex, or political view."

""In the 33 years of its existence, the Wolf Prize has brought great honor to the State of Israel and to scientific activity both in Israel and worldwide," says Minister of Education and Wolf Foundation Council Chairman, Mr. Gideon Sa'ar. "Moreover, the prize has become a predictor of the Nobel: one out of every three Wolf Prize Laureatesin Chemistry, Physics and Medicinehas gone on to receive the Nobel Prize."

Jaenisch and Yamanaka will share the $100,000 prize, which will be awarded by the President of the State of Israel and by the Minister of Education, at a special ceremony at the Knesset at the end of May.

Jaenisch is the second Whitehead Member to receive the Wolf Prize in Medicine. Founding Member Robert Weinberg was so honored in 2004 for his work in tumor genetics.


Contact: Nicole Giese
Whitehead Institute for Biomedical Research

Related biology news :

1. Whitehead Member Rudolf Jaenisch to receive MGHs Warren Triennial Prize
2. Whitehead member Peter Reddien named HHMI Early Career Scientist
3. ESA members take part in National Bed Bug Summit
4. 28 ASPB members elected as AAAS Fellows
5. Plants remember winter to bloom in spring with help of special molecule
6. Agilent Technologies Expands Agreement to Offer AMDeC Members Preferential Pricing on Products Through AMDeC F.I.R.S.T.™ Vendor Partnership Program
7. ASPB members lead new plant genome research program awards
8. The AACR congratulates its members elected to the Institute of Medicine
9. The American Ceramic Society announces 2010 Distinguished Life Members and class of Fellows
10. Biologists meet with members of Congress
11. UC Riverside faculty member joins elite group of entomologists
Post Your Comments:
(Date:10/26/2015)... 26, 2015 ... adds Biometrics Market Shares, Strategies ... well as Emerging Biometrics Technologies: Global ... its collection of IT and Telecommunications ... --> . ...
(Date:10/23/2015)... 23, 2015 Research and Markets ( ... Voice Recognition Biometrics Market 2015-2019" report to their ... The global voice recognition biometrics market to grow ... --> --> The report, ... based on an in-depth market analysis with inputs from ...
(Date:10/22/2015)...  Synaptics (NASDAQ: SYNA ), a leading developer of human ... September 30, 2015. --> --> ... 66 percent over the comparable quarter last year to $470.0 million. ... million, or $0.62 per diluted share. --> ... of fiscal 2016 grew 39 percent over the prior year period ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... 2015 --> ... - 2020 report analyzes that automating biobanking workflow ... in long-term samples, minimizing manual errors, improving the ... manual errors such as mislabeling or inaccurate sample ... plays a vital role in blood fractionation, DNA ...
(Date:11/25/2015)... 25, 2015 2 nouvelles études permettent ... les différences entre les souches bactériennes retrouvées dans la ... des êtres humains . Ces recherches  ouvrent une nouvelle ... prise en charge efficace de l,un des problèmes ... chats .    --> 2 nouvelles études ...
(Date:11/25/2015)... and HOLLISTON, Mass. , Nov. 25, ... HART ), a biotechnology company developing bioengineered organ ... Jim McGorry will present at the LD Micro ... at 2:30 p.m. PT. The presentation will be webcast ... days. Management will also be available at the conference ...
(Date:11/25/2015)... 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS; TSX: ... prospects remain fundamentally strong and highlights the following ... received DSMB recommendation to continue the ZoptEC Phase ... the final interim efficacy and safety data ... men with heavily pretreated castration- and Taxane-resistant prostate ...
Breaking Biology Technology: